Efficacy and Safety Study of Ozanimod in Relapsing Multiple Sclerosis
Clinical trial NCT02047734 · COMPLETED
Trial details
- NCT number
- NCT02047734
- Sponsor
- Celgene
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-03
- Primary completion
- 2017-03-27
- Enrollment
- 1320
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.